《德国邮报》表示,它准备分发COVID - 19疫苗
Deutsche Post says it is ready to distribute COVID-19 vaccine

Deutsche Post says it is ready to distribute COVID-19 vaccine

《德国邮报》表示,它准备分发COVID - 19疫苗

11月10日,柏林(路透社)— —周二,德国物流集团德国邮政集团(Deutsche Post AG)表示,它已做好准备,可以分发针对COVID - 19的潜在疫苗,并正在与制药公司和政府商讨细节,包括冷却的必要性。

此前, 辉瑞和生物技术公司(BioNTech)周一成为首家成功发布试验数据的制药公司,称他们的疫苗已被证明超过90%有效。

德国邮政(Deutsche Post)表示,其合同物流部门在全球各地运营着180多个针对制药业需求的站点,敏感的医疗产品可以在不同温度下储存和包装。

首席执行官弗兰克•阿佩尔(Frank Appel)告诉记者, “由于物流问题,分销不会失败。 ”

周一,生物技术首席执行官乌盖尔•萨欣(Ugur Sahin)对路透社(Reuters)表示,该基因化合物必须以燃离士负70度运输和集中存储。

Sahin说,在行政管理地点的交通,可以在冰箱温度下保存五天,他补充说,他相信物流会很好地运转。

(Emma Thomasson和Matthias Inverardi报告; Maria Sheahan编辑)

BERLIN, Nov 10 (Reuters) - German logistics group Deutsche Post AG said on Tuesday it is well prepared to distribute potential vaccines against COVID-19 and is talking to pharmaceutical companies and governments on the details, including the need for cooling.

The comments come after Pfizer and BioNTech on Monday became the first drugmakers to release successful trial data, saying their vaccine was shown to be more than 90% effective.

Deutsche Post said its contract logistics division operates more than 180 locations worldwide, tailored to the needs of the pharmaceutical industry, where sensitive medical products can be stored and packaged at different temperatures.

"Distribution will not fail because of logistics," Chief Executive Frank Appel told journalists.

BioNTech CEO Ugur Sahin told Reuters on Monday that the genetic compound would have to be shipped and centrally stored at minus 70 degrees Celsius.

For transport to and at the site of administration it can be kept for up to five days at fridge temperatures, Sahin said, adding he was confident logistics would work very well.

(Reporting by Emma Thomasson and Matthias Inverardi; Editing by Maria Sheahan)

BERLIN, Nov 10 (Reuters) - German logistics group Deutsche Post AG said on Tuesday it is well prepared to distribute potential vaccines against COVID-19 and is talking to pharmaceutical companies and governments on the details, including the need for cooling.

11月10日,柏林(路透社)— —周二,德国物流集团德国邮政集团(Deutsche Post AG)表示,它已做好准备,可以分发针对COVID - 19的潜在疫苗,并正在与制药公司和政府商讨细节,包括冷却的必要性。

The comments come after Pfizer and BioNTech on Monday became the first drugmakers to release successful trial data, saying their vaccine was shown to be more than 90% effective.

此前, 辉瑞和生物技术公司(BioNTech)周一成为首家成功发布试验数据的制药公司,称他们的疫苗已被证明超过90%有效。

Deutsche Post said its contract logistics division operates more than 180 locations worldwide, tailored to the needs of the pharmaceutical industry, where sensitive medical products can be stored and packaged at different temperatures.

德国邮政(Deutsche Post)表示,其合同物流部门在全球各地运营着180多个针对制药业需求的站点,敏感的医疗产品可以在不同温度下储存和包装。

"Distribution will not fail because of logistics," Chief Executive Frank Appel told journalists.

首席执行官弗兰克•阿佩尔(Frank Appel)告诉记者, “由于物流问题,分销不会失败。 ”

BioNTech CEO Ugur Sahin told Reuters on Monday that the genetic compound would have to be shipped and centrally stored at minus 70 degrees Celsius.

周一,生物技术首席执行官乌盖尔•萨欣(Ugur Sahin)对路透社(Reuters)表示,该基因化合物必须以燃离士负70度运输和集中存储。

For transport to and at the site of administration it can be kept for up to five days at fridge temperatures, Sahin said, adding he was confident logistics would work very well.

Sahin说,在行政管理地点的交通,可以在冰箱温度下保存五天,他补充说,他相信物流会很好地运转。

(Reporting by Emma Thomasson and Matthias Inverardi; Editing by Maria Sheahan)

(Emma Thomasson和Matthias Inverardi报告; Maria Sheahan编辑)